Molecular Designs is a physician-founded company with a commitment to making molecular technologies that are more cost-effective and easy to use.
From inflation and cost concerns, to supply issues – we understand your challenges.
We help our customers secure lower pricing on research assays and improve workflow.
We offer numerous pathogen assays within 8 different panels, with many more panels in development. Our assays are designed to run on most PCR platforms.
Our high analytical sensitivity and selectivity assays can detect as little as 1-5 copies of DNA or RNA, depending on your needs.
Ready to lower the cost of your PCR assays?
From inflation and cost concerns, to supply issues, we understand your challenges. Our consulting team at Streamline Scientific is ready to build a customized solution to help you lower costs on research assays and improve workflow.
UNIQUELY CAPABLE OF IMPROVING LAB PROFITABILITY
Offering direct-to-customer research assays at the lowest price with no hidden costs. That means everything you need for one low price.
And with improved product efficiency, our clients increase profitability.
Making it easy is in our DNA.
With an expedited analytical validation process and a portfolio of research assays and panels that exceed expectations – our clients receive an unparalleled customer experience.
UPGRADED PRODUCT AND ONGOING PARTNERSHIP
Not only can we help you eliminate supply chain issues by ordering from manufacturing source, we also offer direct access to an agile and robust R&D team, providing collaboration and customization.
Molecular Designs is a team of doctors and scientists working to advance molecular diagnostics.
Our founding physicians entered the molecular diagnostics market focused on the most common pathogens that impact the population – making products that were cost-effective, reduced waste, and easy to use.
Our mission is to simplify the delivery of molecular technologies. We do this by developing, producing, and supplying multiplex assays for research use. We believe individualized molecular data is the foundation for understanding and diagnosing many diseases.
TY THOMAS, M.D.
CHAD AUSTIN, M.D.
Chief Human Capital Officer
Chief Financial Officer
Chief Operating Officer
Chief Commercial Officer
GREER MASSEY, PH.D
Chief Scientific Officer
JENNY MANUEL J.D.
IRENE BACALOCOSTANTIS, PH.D.
VP, Regulatory Affairs
JASPREET SETH, PH.D.
ROBERT CRISP, PH.D
VP of Research and Development